X

Vous n'êtes pas connecté

Maroc Maroc - PHARMABIZ.COM - A la Une - 12/Jul 00:00

OKYO Pharma announces categorical data from OK─101 phase 2 clinical trial in dry eye disease

OKYO Pharma Limited, a clinical─stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi─billion─dollar market, and neuropathic

Articles similaires

Sorry! Image not available at this time

Vico Therapeutics Announces Positive Interim Phase 1/2a Clinical Data of VO659 in Treatment of Huntington's Disease

drugs.com - 14/Sep 05:09

LEIDEN, Netherlands, Sept. 13, 2024. Vico Therapeutics B.V., a clinical-stage genetic medicines company developing therapies for severe neurological...

Laughter exercise could be an initial treatment for relieving dry eye disease symptoms

news.medical.net - 12/Sep 03:08

Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today.

Sorry! Image not available at this time

Aura Biosciences announces positive results from phase 2 end of study of bel─sar as a first─line treatment for early─stage choroidal melanoma

pharmabiz.com - 14/Sep 23:19

Aura Biosciences, Inc., a clinical─stage biotechnology company developing precision therapies for solid tumours designed to preserve organ function,...

Sorry! Image not available at this time

First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

drugs.com - 05/Sep 04:09

NEW YORK, Sept. 4, 2024. Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

Sorry! Image not available at this time

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 03/Sep 01:09

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Laughter Therapy: A New Solution for Dry Eye Disease Relief

medindia.net - 12/Sep 21:05

Discover how laughter exercises may be as effective as eye drops in treating dry eye disease. A new clinical trial reveals surprising results.

Laughter Therapy: A New Solution for Dry Eye Disease Relief

medindia.net - 12/Sep 21:05

Discover how laughter exercises may be as effective as eye drops in treating dry eye disease. A new clinical trial reveals surprising results.

Key paediatric milestone reached in Dimerix’s kidney-disease drug trial

stockhead.com.au - 12/Sep 03:41

Clinical-stage biotech Dimerix has achieved a key milestone with the first paediatric site opening for its ACTION3 Phase 3 clinical ...

Key paediatric milestone reached in Dimerix’s kidney-disease drug trial

stockhead.com.au - 12/Sep 03:41

Clinical-stage biotech Dimerix has achieved a key milestone with the first paediatric site opening for its ACTION3 Phase 3 clinical ...

Sorry! Image not available at this time

Relief Therapeutics presents PKU GOLIKE study results at SSIEM 2024

pharmabiz.com - 03/Sep 00:00

Relief Therapeutics Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare...

Les derniers communiqués

  • Aucun élément